Notice of Intent to Sole Source – QIAGEN

SOL #: 26-002891Special NoticeSole Source

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH - CC
BETHESDA, MD, 20892, United States

Place of Performance

MD

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

Medical And Surgical Instruments, Equipment, And Supplies (6515)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 17, 2026
2
Action Date
Mar 24, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM) has issued a Notice of Intent to Sole Source for annual preventative maintenance services for its QIAGEN instruments. NIH intends to award a fixed price purchase order to QIAGEN, LLC, as they are identified as the sole manufacturer and authorized service provider due to proprietary technology. Interested parties may identify their interest and capabilities by March 24, 2026.

Scope of Work

This acquisition covers annual preventative maintenance services for QIAGEN instruments utilized by the NIH Clinical Center's Department of Laboratory Medicine. The services are critical to ensure the proper maintenance and functionality of the equipment.

Contract & Timeline

  • Type: Fixed Price Purchase Order (Sole Source)
  • Vendor: QIAGEN, LLC (19300 Germantown Rd, Germantown, MD 20874)
  • Reason for Sole Source: QIAGEN is the sole manufacturer and authorized service provider for the instrumentation, citing proprietary technology.
  • Acquisition Method: FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), allowing for solicitation from one source when circumstances deem only one source reasonably available.
  • Place of Performance: Bethesda, MD 20892 USA
  • Response Due: March 24, 2026, at 10:00 AM EST
  • Published: March 17, 2026

Set-Aside

This is a sole source acquisition; therefore, no set-aside designation applies.

Additional Notes

This notice is an intent to award, not a request for quotation, and a solicitation document will not be issued. While interested parties may identify their capabilities, the government's decision not to compete this requirement is at its sole discretion. Comments or statements of interest should reference the posting number and be submitted via email to Kristin Nagashima (Kristin.nagashima@nih.gov).

People

Points of Contact

Kristin NagashimaPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Mar 17, 2026
Notice of Intent to Sole Source – QIAGEN | GovScope